Investment analysts at StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance NASDAQ:INFI opened at $0.01 on Monday. The stock’s fifty day simple moving average […]
Triple-Negative Breast Cancer Clinical Trial Pipeline Insights | 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research note published on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance Infinity Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.01. The company has a market […]
StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance Infinity Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.01. The stock’s 50-day […]
StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance The company has a market cap of $726,000.00, a price-to-earnings ratio of -0.02 and a beta of 1.63. The stock has […]